TY  - GEN
AU  - Phielix,E
AU  - Brehm,A
AU  - Bernroider,E
AU  - Krssak,M
AU  - Anderwald,C-H
AU  - Krebs,M
AU  - Schmid,A I
AU  - Nowotny,P
AU  - Roden,M
TI  - Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
SN  - 1463-1326
PY  - 2014///0519
KW  - Adiponectin
KW  - blood
KW  - Blood Glucose
KW  - metabolism
KW  - Body Mass Index
KW  - C-Reactive Protein
KW  - Cyclohexanes
KW  - therapeutic use
KW  - Diabetes Mellitus, Type 2
KW  - Double-Blind Method
KW  - Female
KW  - Glycated Hemoglobin
KW  - Hepatocytes
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Insulin
KW  - Insulin Resistance
KW  - Lipid Metabolism
KW  - drug effects
KW  - Lipolysis
KW  - Male
KW  - Middle Aged
KW  - Nateglinide
KW  - Phenylalanine
KW  - analogs & derivatives
KW  - Pioglitazone
KW  - Sulfonylurea Compounds
KW  - Thiazolidinediones
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12112
ER  -